[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.v71.3
|
[2] |
钟键, 金正贤, 卞卫星, 等. FGFR3和PIK3CA基因突变影响膀胱癌的预后[J]. 中国癌症杂志, 2019, 29(11): 880-886.
|
|
ZHONG J, JIN Z X, BIAN W X, et al. Effects of FGFR3 and PIK3CA mutations on prognosis of bladder carcinoma[J]. China Oncol, 2019, 29(11): 880-886.
|
[3] |
LENIS A T, LEC P M, CHAMIE K, et al. Bladder cancer: a review[J]. JAMA, 2020, 324(19): 1980-1991.
doi: 10.1001/jama.2020.17598
pmid: 33201207
|
[4] |
CHEN X, XIE R H, GU P, et al. Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2[J]. Clin Cancer Res, 2019, 25(4): 1389-1403.
doi: 10.1158/1078-0432.CCR-18-1656
|
[5] |
XU J, RICHARD S. Cellular pathways influenced by protein arginine methylation: implications for cancer[J]. Mol Cell, 2021, 81(21): 4357-4368.
doi: 10.1016/j.molcel.2021.09.011
pmid: 34619091
|
[6] |
HE H C, CHEN J L, ZHAO J, et al. PRMT7 targets of Foxm1 controls alveolar myofibroblast proliferation and differentiation during alveologenesis[J]. Cell Death Dis, 2021, 12(9): 841.
doi: 10.1038/s41419-021-04129-1
pmid: 34497269
|
[7] |
YAO R S, JIANG H, MA Y H, et al. PRMT7 induces epithelial-to-mesenchymal transition and promotes metastasis in breast cancer[J]. Cancer Res, 2014, 74(19): 5656-5667.
doi: 10.1158/0008-5472.CAN-14-0800
pmid: 25136067
|
[8] |
ASTER J C, PEAR W S, BLACKLOW S C. The varied roles of Notch in cancer[J]. Annu Rev Pathol, 2017, 12: 245-275.
doi: 10.1146/annurev-pathol-052016-100127
pmid: 27959635
|
[9] |
LI W J, HE Y H, YANG J J, et al. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth[J]. Nat Commun, 2021, 12(1): 1946.
doi: 10.1038/s41467-021-21963-1
|
[10] |
JEONG H J, LEE S J, LEE H J, et al. PRMT7 promotes myoblast differentiation via methylation of p38MAPK on arginine residue 70[J]. Cell Death Differ, 2020, 27(2): 573-586.
doi: 10.1038/s41418-019-0373-y
|
[11] |
CHEN M, WANG Y B, LIN L M, et al. PRMT7 is involved in regulation of germ cell proliferation during embryonic stage[J]. Biochem Biophys Res Commun, 2020, 533(4): 938-944.
doi: 10.1016/j.bbrc.2020.09.099
|
[12] |
LIU L X, ZHANG X L, DING H Y, et al. Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS[J]. Oncogene, 2021, 40(20): 3548-3563.
doi: 10.1038/s41388-021-01785-7
pmid: 33927350
|
[13] |
SHEN T, NI T, CHEN J X, et al. An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression[J]. Nat Commun, 2022, 13(1): 1232.
doi: 10.1038/s41467-022-28861-0
pmid: 35264579
|
[14] |
ROPER N, VELEZ M J, CHIAPPORI A, et al. Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer[J]. Nat Commun, 2021, 12(1): 3880.
doi: 10.1038/s41467-021-24164-y
pmid: 34162872
|
[15] |
GENG Y W, FAN J, CHEN L Y, et al. A Notch-dependent inflammatory feedback circuit between macrophages and cancer cells regulates pancreatic cancer metastasis[J]. Cancer Res, 2021, 81(1): 64-76.
doi: 10.1158/0008-5472.CAN-20-0256
pmid: 33172931
|
[16] |
HE H D, SHAO X N, LI Y N, et al. Targeting signaling pathway networks in several malignant tumors: progresses and challenges[J]. Front Pharmacol, 2021, 12: 675675.
doi: 10.3389/fphar.2021.675675
|
[17] |
ZHOU B H, LIN W L, LONG Y L, et al. Notch signaling pathway: architecture, disease, and therapeutics[J]. Signal Transduct Target Ther, 2022, 7(1): 95.
|
[18] |
HARADA Y, YAMADA M, IMAYOSHI I, et al. Cell cycle arrest determines adult neural stem cell ontogeny by an embryonic Notch-nonoscillatory Hey1 module[J]. Nat Commun, 2021, 12(1): 6562.
doi: 10.1038/s41467-021-26605-0
pmid: 34772946
|
[19] |
ZHU J J, LI X, CAI X L, et al. Arginine monomethylation by PRMT7 controls MAVS-mediated antiviral innate immunity[J]. Mol Cell, 2021, 81(15): 3171-3186.e8.
doi: 10.1016/j.molcel.2021.06.004
|